Cargando…
COVID-19 outcomes in persons with hemophilia: results from a US-based national COVID-19 surveillance registry
INTRODUCTION: Hypercoagulable state contributing to thrombotic complications worsens COVID-19 severity and outcomes, while anticoagulation improves outcomes by alleviating hypercoagulability. OBJECTIVES: Examine whether hemophilia, an inherent hypocoagulable condition, offers protection against COVI...
Autores principales: | Sharathkumar, Anjali, Wendt, Linder, Ortman, Chris, Srinivasan, Ragha, Chute, Christopher, Chrischilles, Elizabeth, Takemoto, Clifford |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10181864/ https://www.ncbi.nlm.nih.gov/pubmed/37182697 http://dx.doi.org/10.1016/j.jtha.2023.04.040 |
Ejemplares similares
-
How we approach thrombosis risk in children with COVID‐19 infection and MIS‐C
por: Sharathkumar, Anjali A., et al.
Publicado: (2021) -
Review of Potential Barriers to Effective Hemostatic Management of Acquired Hemophilia A by Non-Hemophilia Experts in the United States
por: Sharathkumar, Anjali, et al.
Publicado: (2023) -
Thromboprophylaxis for children hospitalized with COVID‐19 and MIS‐C
por: Schmitz, Anna H., et al.
Publicado: (2022) -
DOACs and “newer” hemophilia therapies in COVID‐19: Reply
por: Thachil, Jecko, et al.
Publicado: (2020) -
Musculoskeletal Changes in Hemophilia Patients Subsequent to COVID−19 Lockdown
por: Cuesta-Barriuso, Rubén, et al.
Publicado: (2021)